[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Tianjin Tasly Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Tasly Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tianjin TEDA Biomedical Engineering Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin TEDA Biomedical Engineering Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tianjin Tianyao Pharmaceutical Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Tianyao Pharmaceutical Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tianyin Pharmaceutical Co., Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianyin Pharmaceutical Co., Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tibet Cheezheng Tibetan Medicine Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tibet Cheezheng Tibetan Medicine Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tien Liang Biotech Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tien Liang Biotech Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

TiGenix N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TiGenix N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tikcro Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tikcro Technologies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tissera Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tissera Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Factor Therapeutics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Factor Therapeutics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Titan Biotech Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Titan Biotech Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Titan Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Titan Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tong Ren Tang Technologies Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tong Ren Tang Technologies Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tonghua Dongbao Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tonghua Dongbao Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tongjitang Chinese Medicines Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tongjitang Chinese Medicines Co. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tongli Pharmaceuticals (USA), Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tongli Pharmaceuticals (USA), Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tonira Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tonira Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

TopoTarget A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TopoTarget A/S Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Topsun Science And Technology Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Topsun Science And Technology Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Torii Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Torii Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Torrent Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Torrent Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Towa Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Towa Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Trans Genic Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trans Genic Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transcept Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transcept Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transchem Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transchem Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transdel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transdel Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transgene Biotek Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transgene Biotek Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transgene SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transgene SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transgenomic Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transgenomic Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Transition Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transition Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Trimeris Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trimeris Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Trinity Medical Group USA Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trinity Medical Group USA Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

TrioBiotics Pharma AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TrioBiotics Pharma AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Triochem Products Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Triochem Products Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Trius Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trius Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

TrovaGene, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TrovaGene, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

LegacyXChange, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

LegacyXChange, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

TrueYou.com, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TrueYou.com, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tsumura & Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tsumura & Co. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

TTK Healthcare Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TTK Healthcare Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Twilight Litaka Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Twilight Litaka Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tyche Industries Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tyche Industries Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Contango Asset Management Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Contango Asset Management Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Tyson Bioresearch Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tyson Bioresearch Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

UCB SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

UCB SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

ULURU Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ULURU Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Unichem Laboratories Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unichem Laboratories Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Unigene Laboratories Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Unigene Laboratories Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers